Back
Day Range
$13.03
$13.80
52-Week Range
$3.35
$16.33
Volume
137,766
50D / 200D Avg
$13.74
/
$10.26
Prev Close
$13.28
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.5 | 0.2 |
| P/B | 2.0 | 2.9 |
| ROE % | -26.1 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -55.54M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-26.13%
ROIC-18.96%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.03
Current Ratio27.50
Interest Coverage0.00
Valuation
P/E Ratio
-8.50
Forward P/EN/A
P/B Ratio1.95
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -59.98M |
| ROE | -26.13% | ROA | -21.68% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -55.54M |
| ROIC | -18.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 27.50 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.50 | Forward P/E | N/A |
| P/B Ratio | 1.95 | P/S Ratio | N/A |
| PEG Ratio | 11.51 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -10.90% | ||
| Market Cap | 509.64M | Enterprise Value | 442.28M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 50.00M | 0.0 | 0.0 |
| Net Income | -59.98M | -42.26M | 22.72M | -24.25M | -29.00M |
| EPS (Diluted) | -2.17 | -2.18 | 0.90 | -0.97 | -1.15 |
| Gross Profit | -323,000.0 | -258,000.0 | 50.00M | -329,000.0 | 0.0 |
| Operating Income | -68.06M | -50.89M | -16.08M | -22.72M | -28.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 276.64M | 212.85M | 130.39M | 50.64M | 70.52M |
| Total Liabilities | 15.65M | 14.78M | 198.32M | 11.37M | 8.93M |
| Shareholders' Equity | 260.99M | 198.07M | -67.94M | 39.27M | 61.59M |
| Total Debt | 8.25M | 6.26M | 193.19M | 5.85M | 4.91M |
| Cash & Equivalents | 75.60M | 21.94M | 15.53M | 5.57M | 4.63M |
| Current Assets | 267.92M | 206.39M | 127.71M | 48.39M | 69.78M |
| Current Liabilities | 9.74M | 9.97M | 5.48M | 7.55M | 3.67M |